Cardiovascular Risk Prediction Models in People Living with HIV in Colombia

Angel A García-Peña1, Esther De-Vries2, Jairo Aldana-Bitar3

  • 1PhD Program in Clinical Epidemiology and Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Bogotá, Cardiology Division; Department of Internal Medicine; Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.

Insights

Cardiovascular risk scores showed acceptable performance in predicting major adverse cardiovascular events (MACE) for people living with HIV. These tools aid in managing cardiovascular risk in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Individuals with HIV face elevated cardiovascular disease (CVD) risk.
  • Cardiovascular risk (CVR) prediction scores are vital for personalized patient management.
  • These scores guide decisions on follow-up, lipid-lowering therapy, and antiretroviral treatment.

Purpose of the Study:

  • To assess the predictive accuracy of various CVR scores for major adverse cardiovascular events (MACE) over 5 and 10 years in an HIV-infected cohort.
  • To compare the performance of Framingham, SCORE, PROCAM, ASCVD, and D:A:D scores.

Main Methods:

  • Data from a Colombian HIV registry were analyzed.
  • 808 adult patients with complete data for CVR score calculation and MACE determination were included.
  • Receiver operating characteristic (ROC) curves were used to evaluate score performance.

Main Results:

  • The study included 808 patients (mean age 35, 12% female).
  • Most patients presented with low to very low CVR.
  • All evaluated scores demonstrated acceptable performance, with no statistically significant differences in their predictive accuracy (Area Under ROC curves ranging from 0.89 to 0.92).

Conclusions:

  • The assessed cardiovascular risk scores performed acceptably in HIV-infected individuals.
  • These scores are particularly useful for identifying patients in low and very low cardiovascular risk categories.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
418
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
809
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
542
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
299
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
1.8K